Our study found that the FOXO4 was a significantly protective factor in DSS, OS, and PFS for THYM, MESO, LGG, and KIRC, while a high risk factor in DFS, OS, and PFS for DLBC (diffuse large B-cell lymphoma). Here, FOXO4 is linked to diffuse large B-cell lymphoma.